Academe Learn
CBME Curriculum Preview

Page 15 of 15

CM11.1-6 | Occupational Health — PBL Case

CLINICAL SETTING

Ravi Textile Dyes Pvt Ltd is a medium-scale synthetic dye manufacturing plant in Surat, Gujarat, employing 420 workers. The plant uses naphthalene-derived intermediates, strong acids, and solvents in enclosed mixing vats. On a Tuesday afternoon, the district health officer receives an urgent call from the plant's contract nurse: within the past 6 weeks, 9 workers from the dye-synthesis department have been admitted to the district hospital — 5 with haematuria and dysuria (urinary symptoms), 2 with anaemia and peripheral neuropathy, and 2 with skin rashes and jaundice. The nurse adds that the factory has no full-time Medical Officer, safety officer, or formal health surveillance programme. Most workers are daily-wage earners who fear losing their jobs if they report symptoms.

Trigger 1: The Cluster Investigation Begins

You arrive at the district hospital to assess the 5 workers with urinary symptoms. All are male, aged 28–47 years, with 5–14 years of service in the dye-synthesis department. Three have macroscopic haematuria; two have microscopic haematuria with dysuria and urgency. Urine cytology in two workers shows atypical transitional cells. None of them smoke. No infections are identified on urine culture. The plant's safety data sheets (reviewed by a colleague) list 2-naphthylamine (beta-naphthylamine) as an intermediate in their azo-dye synthesis process. The plant manager says workers handle the compound 'occasionally' without respirators.

DISCUSSION POINTS

  • What occupational carcinogen is most likely responsible for the urinary symptoms in this cluster, and through what biological mechanism does it cause bladder cancer?
  • What is the typical latency period between first exposure to beta-naphthylamine and development of bladder transitional cell carcinoma?
  • What specific workplace practices and hygiene failures could explain why 9 workers have been affected within the same department?
  • What immediate steps should you recommend for these 5 workers — investigation, referral, and documentation?
Click to reveal Trigger 2: More Exposures Revealed (discuss previous trigger first!)

Trigger 2: More Exposures Revealed

On plant inspection you discover: (a) two workers handling lead-based catalysts present with anaemia, wrist-drop, and abdominal colic; (b) three workers in the azo-dyeing vat area complain of numbness and tremor — they work with mercury-containing compounds used as catalysts; (c) the two jaundiced workers handled 2-naphthylamine directly and had no pre-placement or periodic screening. Review of work records reveals workers rotate between sections without health assessments. ESI registration exists, but only 160 of the 420 workers are enrolled (wage ceiling confusion cited by the HR manager). A welfare officer was never appointed despite worker count exceeding the statutory threshold.

DISCUSSION POINTS

  • Match each symptom complex (wrist-drop + anaemia + colic; tremor + numbness; haematuria + jaundice) to its specific heavy metal or chemical exposure and explain the pathophysiology.
  • Which workers in this plant are legally entitled to ESI coverage, and what ESI benefits should the 9 affected workers be claiming right now? Identify the HR manager's error in applying the wage ceiling.
  • Under the Factories Act 1948, list ALL statutory violations you have identified in this plant (welfare officer, safety officer, surveillance, OHC, PPE, records).
  • For the workers with heavy metal toxicity, what biological monitoring parameters (blood/urine) would confirm exposure, and what are the actionable thresholds?
Click to reveal Trigger 3: System Design and Prevention (discuss previous trigger first!)

Trigger 3: System Design and Prevention

The District Collector has ordered the plant to suspend operations in the dye-synthesis and catalyst departments pending an inspection. The plant owner has agreed to implement a full occupational health programme under your guidance as the newly appointed Factory Medical Officer. All 420 workers need health screening. The nine affected workers require compensation and rehabilitation. State health authorities want an outbreak investigation report.

DISCUSSION POINTS

  • Design a hierarchy-of-controls intervention plan for the dye-synthesis department: what would you eliminate, substitute, engineer, administer, and what PPE would you specify?
  • Outline the components of the pre-placement and periodic health surveillance programme you would implement — which tests, at what frequency, and for which exposure groups?
  • Compose the ESI disablement benefit application process for the worker with lead-induced wrist-drop (permanent partial disability). What percentage of disability needs to be assessed, and who assesses it?
  • What are your key recommendations in the outbreak investigation report to state authorities to prevent recurrence — covering legislation, compensation, and primary prevention?

Group Task Assignments

Group 1: Occupational Carcinogenesis — Beta-naphthylamine and Bladder Cancer

  • Explain the mechanism by which beta-naphthylamine (a pro-carcinogen) is converted to its active carcinogenic form in the body, and why the bladder is the primary target organ.
  • List five other occupational carcinogens and their target organs in a table (agent → industry → cancer type), including at least one from the Indian context.

Competencies: CM11.1, CM11.3

Group 2: Heavy Metal Toxicology — Lead and Mercury

  • Compare lead and mercury poisoning: occupational sources, mechanism of toxicity, clinical features, biological monitoring parameters, actionable thresholds, and treatment for each.
  • Using the case data (worker with wrist-drop, anaemia, and colic), outline the sequence of investigation from clinical suspicion to confirmed occupational lead poisoning per Indian clinical practice.

Competencies: CM11.1, CM11.3

Group 3: ESI Act — Coverage, Benefits, and Disablement

  • Determine which categories of workers at Ravi Textile Dyes are legally covered under ESI (wage ceiling, factory size threshold, categories of covered employment).
  • Prepare a fact sheet for the 9 affected workers: which ESI benefits apply (sickness, disablement, medical care, dependent), how to initiate claims, and what the HR manager should have done differently.

Competencies: CM11.2

Group 4: Factories Act — Statutory Compliance Audit

  • Using the Factories Act 1948, identify all specific sections that are violated in this plant (e.g., Section 40-B Safety Officer, welfare officer, OHC, health surveillance records, PPE provisions). For each violation, state the section number, threshold, and what should have been done.
  • Outline the enforcement mechanisms available to state factory inspectors to compel compliance — including penalties, closure orders, and improvement notices.

Competencies: CM11.3, CM11.6

Group 5: Healthcare Worker Occupational Health — Prevention Programme Design

  • As the incoming Factory Medical Officer for this plant, design the occupational health surveillance programme: pre-placement assessment, periodic surveillance schedule (by exposure group), emergency response protocol, and fitness-for-work criteria for chemical exposure areas.
  • Propose three measurable process indicators and three measurable outcome indicators you would use to evaluate the programme's effectiveness after one year.

Competencies: CM11.4, CM11.5, CM11.6

Learning Issues

Research these questions and bring your findings to the discussion.

  1. [CM11.1] Describe the presenting clinical features of the principal occupational diseases caused by chemical hazards in manufacturing (heavy metals, aromatic amines), including diagnostic criteria and biological monitoring.
  2. [CM11.2] Explain the structure, contribution rates, wage ceiling, and cash benefits of the ESI Scheme — particularly sickness benefit, disablement benefit, and medical benefit — with eligibility criteria and claim procedures.
  3. [CM11.3] Describe the occupational exposure limits, risk factors, biological monitoring thresholds, and preventive measures for lead, mercury, and aromatic amines in Indian industry.
  4. [CM11.4] Explain the principles of ergonomics as applied to chemical plant work (manual handling, workstation design, heat stress, shift work) and how violation of ergonomic principles contributes to musculoskeletal and psychosocial disorders.
  5. [CM11.5] Describe the specific occupational health hazards faced by Factory Medical Officers and other healthcare workers, their prevention strategies, and the legal and ethical obligations when managing occupationally exposed patients.
  6. [CM11.6] Outline the components of a statutory occupational health service for a medium-scale chemical factory in India: pre-placement and periodic surveillance, emergency medical response, record-keeping, and evaluation under the Factories Act 1948.